Private company
YM Biosciences
YM BioSciences Inc. was a Canadian drug development company primarily focused on advancing CYT-387, an orally administered inhibitor of both the JAK1 and JAK2 kinases, which have been implicated in a number of hematological and immune cell disorders including myeloproliferative neoplasms and inflammatory diseases as well as certain cancers.2 It is headquartered in Toronto.1 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
- HeadquartersToronto1
See how the biggest companies compare on our leaderboards
YM BioSciences Inc. was a Canadian drug development company primarily focused on advancing CYT-387, an orally administered inhibitor of both the JAK1 and JAK2 kinases, which have been implicated in a number of hematological and immune cell disorders including myeloproliferative neoplasms and inflammatory diseases as well as certain cancers.2
Products and brands
- momelotinib
Listed on Wikidata.1
Links
- WikipediaYM Biosciences
- WikidataQ28408407
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataYM Biosciences on Wikidata
- 2WikipediaYM Biosciences on Wikipedia